WEC
RDY icon

Winslow Evans & Crocker’s Dr. Reddy's Laboratories RDY Stock Holding History

Winslow Evans & Crocker’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,745
Closed -$15.8K – 1303
2016
Q1 		$15.8K Sell
1,745
-5
-0.3% -$45 ﹤0.01% 758
2015
Q4 		$16.2K Hold
1,750
– – ﹤0.01% 797
2015
Q3 		$22.3K Hold
1,750
– – 0.01% 693
2015
Q2 		$19.3K Hold
1,750
– – 0.01% 769
2015
Q1 		$19.9K Hold
1,750
– – 0.01% 734
2014
Q4 		$17.6K Hold
1,750
– – 0.01% 762
2014
Q3 		$18.3K Buy
+1,750
New +$16.5K 0.01% 755

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Winslow Evans & Crocker's RDY Position: Q2 2016 in Review

Winslow Evans & Crocker sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 1,745 shares — an estimated $15.8K sold.

Winslow Evans & Crocker first reported a position in RDY in Q3 2014 and held it in 7 quarters. The position peaked at $22.3K in Q3 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

  • Winslow Evans & Crocker reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,745 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $15.8K.
  • Winslow Evans & Crocker first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 7 quarters.
  • Winslow Evans & Crocker's Dr. Reddy's Laboratories position peaked at $22.3K in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on Winslow Evans & Crocker's 13F filing for Q2 2016, filed 22 Jul 2016.